Guideline-concordant antibiotic prescribing for community-acquired bacterial pneumonia (CABP) due to drug resistant pathogens in the All of Us database
Year: 2026
Type: dissertation
Study design: Observational Study
Abstract: Introduction: Community-acquired bacterial pneumonia (CABP) contributes significantly to mortality and healthcare costs worldwide. The use of guideline-concordant antibiotic therapy for CABP is associated with improved outcomes. Methods: This was a retrospective cohort study of inpatients with CABP due to MRSA or P. aeruginosa in the All of Us database. The proportion of patients on guideline-concordant antibiotics or guideline-discordant antibiotics was compared within groups based upon patient age, sex, self-reported race, ethnicity, marital status, alcohol use, and tobacco use. Guideline concordance was determined using the 2019 IDSA/ATS CABP guidelines. Associations were further analyzed using multivariate logistic regression. Results: A total of 336 patients with CABP due to MRSA (152) or P. aeruginosa (184) were included. Guideline-concordant antibiotic therapy was prescribed to 70% of CABP-MRSA patients and for 57% of CABP-P. aeruginosa patients. The single independent predictive factor of guideline-concordant antibiotic prescribing for CABP-P. aeruginosa patients was Non-Hispanic Black (NHB) vs. Non-Hispanic White (NHW) race (Odds ratio = 0.30, 95% Confidence interval = 0.12 – 0.75). There were no independent predictive factors of guideline-concordant antibiotic prescribing for CABP-MRSA. Conclusion: In the All of Us database, the majority of CABP-MRSA and CABP-P. aeruginosa patients were prescribed guideline-concordant antibiotic therapy. Race was independently predictive of guideline-concordant antibiotic therapy for patients with CABP-Pseudomonas aeruginosa, but not CABP-MRSA. NHB patients were less likely to receive guideline-concordant antibiotic therapy than NHW patients when treated for CABP-P. aeruginosa.
DOI: 10.26153/tsw/64615
Author: Gilmore, Corbyn Montgomery
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7204255540
